Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis

Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis and pregnancy

Not Recommended

• Fetal development
• Absorbed into the body

Cannabidiol (CBD) is a cannabinoid compound extracted from cannabis plants that has anti-inflammatory and antioxidant properties. While CBD itself is non-psychoactive, it can be absorbed through the skin, particularly in oil-based formulations. The FDA and ACOG strongly recommend avoiding all cannabis products, including CBD, during pregnancy. While research on topical CBD specifically is limited, studies on oral CBD and cannabis use show potential risks to fetal brain development and endocannabinoid system disruption. The endocannabinoid system plays a crucial role in fetal neurodevelopment, and external cannabinoids may interfere with this process. Animal studies have shown developmental concerns with cannabinoid exposure. Most obstetricians recommend complete avoidance of CBD products during pregnancy due to insufficient safety data and theoretical risks to fetal development. The uncertain regulatory status and lack of standardized testing for purity and THC contamination add additional concerns.

Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis and breastfeeding

Not Recommended

• Passes into breast milk
• Infant exposure

Cannabidiol (CBD) is a lipophilic (fat-soluble) compound that can be absorbed through the skin. Due to its fat-soluble nature, there is potential for it to accumulate in tissues and be transferred into breast milk. The AAP (American Academy of Pediatrics) and ACOG advise against all cannabis product use during breastfeeding, including topical CBD. While specific data on topical CBD transfer to breast milk is limited, the fat-soluble nature of cannabinoids raises concerns about accumulation and infant exposure. The developing infant brain is particularly sensitive to cannabinoid exposure, and the long-term effects are unknown. Most pediatricians and lactation consultants recommend avoiding CBD products while breastfeeding due to theoretical risks and lack of safety data. The concern is heightened by inconsistent product labeling and potential THC contamination in CBD products.

Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis and postpartum

Safe to Use

For postpartum women who are not breastfeeding, topical CBD can provide anti-inflammatory and soothing benefits that may help with skin recovery and stress-related skin issues. When not breastfeeding, the primary concerns associated with CBD use do not apply. Topical CBD is generally well-tolerated and may offer benefits for inflammation and skin comfort during the postpartum period.

Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis and trying to conceive

Caution Advised

• Fertility effects

Cannabidiol (CBD) is a cannabinoid that can be absorbed through the skin. While topical absorption is lower than oral consumption, the endocannabinoid system plays a role in reproductive function. Due to the endocannabinoid system's involvement in fertility and early pregnancy, many fertility specialists recommend discontinuing CBD products when actively trying to conceive. While specific data on topical CBD and conception is limited, a precautionary approach is typically advised given the unknowns about cannabinoid effects on implantation and early embryo development.

Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis and PCOS

Safe to Use

Cannabidiol (CBD) has anti-inflammatory and sebum-regulating properties that may be beneficial for PCOS-related acne and skin inflammation. It works through the endocannabinoid system receptors in the skin. Emerging research suggests CBD may help regulate sebum production and reduce inflammation, which are common concerns for women with PCOS. While studies are still limited, the anti-inflammatory effects could be helpful for managing hormonal acne. There is no evidence that topical CBD interferes with hormonal balance or affects insulin sensitivity in women with PCOS. However, women should be aware of product quality variations and potential allergens in CBD formulations.

Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis and general use

Safe to Use

• Common allergen

Cannabidiol (CBD) is a non-psychoactive compound from cannabis plants used in skincare for its anti-inflammatory, antioxidant, and calming properties. It interacts with the skin's endocannabinoid system to help regulate inflammation and sebum production. For the general population, topical CBD is generally well-tolerated with a low risk of side effects. Some individuals may experience mild irritation or allergic reactions. The main concerns relate to product quality, as the CBD industry is not well-regulated, leading to inconsistent potency and potential contamination with THC or other substances. While the FDA has not approved CBD in cosmetics, enforcement has been minimal for topical products. The EU allows hemp-derived CBD when THC content is below legal limits. Consumers should look for third-party tested products to ensure quality and purity.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding
• Flagged in trying to conceive

Related ingredients

Ingredients suggested in place of Cannabidiol, Derived From Extract Or Tincture Or Resin Of Cannabis, each one with its own page here.

• Niacinamide
• Allantoin
• Bisabolol
• Colloidal Oatmeal
• Azelaic Acid

Ingredients that raise the same concerns.

• Benzophenone-4Fertility effects, Fetal development, Infant exposure
• Benzophenone-3Fertility effects, Fetal development, Infant exposure
• Juniperus Mexicana OilFertility effects, Fetal development, Infant exposure
• TriclosanFertility effects, Fetal development, Infant exposure
• ResorcinolFertility effects, Fetal development, Infant exposure
• TBHQFertility effects, Fetal development, Infant exposure

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.